NYSE: BAK
Braskem Sa Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their BAK stock forecasts and price targets.

Forecast return on equity

Is BAK forecast to generate an efficient return?

Company
-59.06%
Industry
5.52%
Market
75.61%
BAK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BAK forecast to generate an efficient return on assets?

Company
2.78%
Industry
2.48%
BAK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BAK earnings per share forecast

What is BAK's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.07
Avg 2 year Forecast
$0.62

BAK revenue forecast

What is BAK's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$15.1B+20.4%
Avg 2 year Forecast
$16.0B+27.4%
BAK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BAK revenue growth forecast

How is BAK forecast to perform vs Chemicals companies and vs the US market?

Company
12.22%
Industry
0.86%
Market
58.64%
BAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BAK vs Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
BAK$3.82N/AN/A
MEOH$28.76$49.50+72.11%Buy
TROX$5.42$12.93+138.54%Strong Buy
WLKP$23.63N/AN/A
HUN$13.08$17.67+35.07%Hold

Braskem Sa Stock Forecast FAQ

What is BAK's earnings growth forecast for 2025-2026?

(NYSE: BAK) Braskem Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Chemicals industry's average forecast earnings growth rate of -23.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 72.53%.

Braskem Sa's earnings in 2025 is -$1,965,277,777.On average, 2 Wall Street analysts forecast BAK's earnings for 2025 to be -$51,818,509, with the lowest BAK earnings forecast at -$95,664,940, and the highest BAK earnings forecast at -$7,972,078.

In 2026, BAK is forecast to generate $490,282,818 in earnings, with the lowest earnings forecast at -$239,162,350 and the highest earnings forecast at $1,219,727,986.

If you're new to stock investing, here's how to buy Braskem Sa stock.

What is BAK's revenue growth forecast for 2025-2026?

(NYSE: BAK) Braskem Sa's forecast annual revenue growth rate of 12.22% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 0.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.64%.

Braskem Sa's revenue in 2025 is $13,439,409,722.On average, 2 Wall Street analysts forecast BAK's revenue for 2025 to be $12,023,285,264,390, with the lowest BAK revenue forecast at $11,513,363,231,490, and the highest BAK revenue forecast at $12,533,207,297,291.

In 2026, BAK is forecast to generate $12,721,982,126,343 in revenue, with the lowest revenue forecast at $12,480,551,719,855 and the highest revenue forecast at $12,963,412,532,831.

What is BAK's forecast return on assets (ROA) for 2025-2026?

(NYSE: BAK) forecast ROA is 2.78%, which is higher than the forecast US Chemicals industry average of 2.48%.

What is BAK's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSE: BAK) Braskem Sa's current Earnings Per Share (EPS) is -$4.93. On average, analysts forecast that BAK's EPS will be -$0.07 for 2025, with the lowest EPS forecast at -$0.12, and the highest EPS forecast at -$0.01. In 2026, BAK's EPS is forecast to hit $0.62 (min: -$0.30, max: $1.53).

What is BAK's forecast return on equity (ROE) for 2025-2026?

(NYSE: BAK) forecast ROE is -59.06%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.